Palo Santo (Bursera graveolens)
Palo Santo (Bursera graveolens) contains limonene and α-terpineol as primary bioactive compounds that exhibit antimicrobial and anti-proliferative properties. These terpenes work by disrupting cellular membranes in microorganisms and potentially interfering with cancer cell proliferation pathways.

Origin & History
Palo Santo (Bursera graveolens) is a wild tree native to the Neotropics, particularly Peru, valued in traditional medicine and commercial applications. The essential oil is extracted from aged heartwood via hydrodistillation or steam distillation, yielding a pale yellow oil rich in monoterpenes including α-terpinene (up to 31.57%) and limonene (26.5%).
Historical & Cultural Context
Palo Santo has been widely used in Neotropical folk medicine, particularly in Peru for antimicrobial purposes. The tree has historical significance in South American traditional medicine systems, though specific durations of use and detailed traditional applications are not well documented.
Health Benefits
• Antimicrobial activity: Demonstrated strong inhibition against seven microorganisms with inhibition zones up to 18.3 ± 2.6 mm (in vitro evidence only) • Anti-proliferative effects: Inhibited MCF-7 breast tumor cell growth with IC50 of 48.9 ± 4.3 μg/mL (preliminary in vitro study) • Anti-parasitic activity: Showed activity against Leishmania amazonensis amastigotes with IC50 of 36.7 ± 4.7 μg/mL (in vitro evidence) • Antioxidant properties: Demonstrated DPPH radical scavenging activity, though characterized as weak (in vitro study) • Traditional antimicrobial use: Historically used in Peruvian folk medicine for antimicrobial purposes (traditional evidence only)
How It Works
Palo Santo's primary bioactive compounds limonene and α-terpineol disrupt microbial cell membrane integrity, leading to cell death through osmotic imbalance. The anti-proliferative effects against cancer cells likely involve interference with cell cycle progression and induction of apoptosis pathways. These terpenes may also modulate inflammatory responses by inhibiting pro-inflammatory cytokine production.
Scientific Research
No human clinical trials, randomized controlled trials, or meta-analyses have been conducted on Palo Santo. Available research consists of in vitro studies showing anti-proliferative effects against MCF-7 breast cancer cells and antimicrobial activity (PMID: 23285824). Sample sizes and standardization were not specified in the available preclinical studies.
Clinical Summary
Current evidence for Palo Santo consists primarily of in vitro laboratory studies with no human clinical trials available. Antimicrobial testing showed inhibition zones of up to 18.3 ± 2.6 mm against seven different microorganisms. Anti-cancer research demonstrated MCF-7 breast cancer cell growth inhibition with an IC50 value of 48.9 ± 4.3 μg/mL. While these preliminary results are promising, human studies are needed to establish therapeutic efficacy and safe dosing protocols.
Nutritional Profile
{"macronutrients": {"fiber": "Not applicable", "protein": "Not applicable"}, "micronutrients": {"vitamins": "Not applicable", "minerals": "Not applicable"}, "bioactive_compounds": {"limonene": "Approximately 20-30% of essential oil content", "\u03b1-terpineol": "Approximately 10-15% of essential oil content", "menthofuran": "Approximately 5-10% of essential oil content"}, "bioavailability_notes": "The bioactive compounds are primarily found in the essential oil extracted from the wood of Palo Santo. These compounds are volatile and may be absorbed through inhalation or topical application, but ingestion is not typical due to the nature of the product."}
Preparation & Dosage
No clinically studied human dosages exist. In vitro studies used essential oil concentrations of 36.7-103.9 μg/mL for anti-proliferative effects and up to 800 μg/mL for antioxidant assays. No standardized extracts or recommended human doses have been established. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Other antimicrobial essential oils, Frankincense, Myrrh, Copal, Tea Tree oil
Safety & Interactions
Safety data for Palo Santo supplementation is extremely limited due to lack of human clinical trials. Traditional use suggests generally good tolerance, but potential allergic reactions may occur in sensitive individuals. No documented drug interactions exist, though theoretical interactions with antimicrobial medications could occur. Pregnant and breastfeeding women should avoid use due to insufficient safety data and unknown effects on fetal development.